National Health Investors, Inc. (NHI) — Financial statements
Income statement, balance sheet, and cash flow for National Health Investors, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 379↑12.9% | 335↑4.8% | 320↑15.0% | 278↓6.9% | 299 | |
| Cost of Revenue | 240↑2046.0% | 11↓3.0% | 12↑17.6% | 10↓15.9% | 12 | |
| Gross Profit | 139↓57.1% | 324↑5.1% | 308↑14.9% | 268↓6.5% | 287 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00↓100.0% | 22↑9.9% | 20↓21.7% | 25↑30.9% | 19 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 0.00↓100.0% | 22↑9.9% | 20↓21.7% | 25↑30.9% | 19 | |
| Other Expenses | -56↓147.2% | 118↑7.9% | 110↓0.6% | 110↑33.7% | 82 | |
| Operating Expenses | -56↓139.9% | 140↑8.2% | 130↓4.5% | 136↑33.2% | 102 | |
| Total Costs & Expenses | 184↑21.4% | 151↑7.3% | 141↓3.0% | 145↑28.2% | 113 | |
| Operating Results | ||||||
| Operating Income | 195↑6.0% | 184↑2.8% | 179↑34.7% | 133↓28.3% | 185 | |
| Depreciation & Amortization | 84↑17.4% | 71↑2.1% | 70↓1.3% | 71↓12.3% | 81 | |
| EBITDA | 282↑6.8% | 264↑1.7% | 260↑45.4% | 179↓25.8% | 241 | |
| EBIT | 198↑2.8% | 193↑1.5% | 190↑76.1% | 108↓32.7% | 160 | |
| Interest & Other Income | ||||||
| Net Interest Income | -34↑40.2% | -56↑3.5% | -58↓37.0% | -42↑11.8% | -48 | |
| Interest Income | 24 | 0.00↑100.0% | -3 | 0.00 | 0.00 | |
| Interest Expense | 57↑2.2% | 56↑1.1% | 56↑30.8% | 42↓11.8% | 48 | |
| Non-Operating Income | -3↑62.4% | -9↑20.2% | -11↓144.6% | 25↓0.8% | 25 | |
| Other Income / Expenses | -54↓14.3% | -47↓6.4% | -44↑34.1% | -67↑8.0% | -73 | |
| Income Before Tax | 141↑3.1% | 137↑1.6% | 134↑105.4% | 65↓41.6% | 112 | |
| Income Tax Expense | 0.00↑100.0% | -0.05 | 0.00↑100.0% | -0.09↓234.8% | 0.07 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 141↑3.0% | 137↑1.7% | 134↑105.2% | 66↓41.5% | 112 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 142↑3.0% | 138↑1.7% | 136↑104.3% | 66↓40.6% | 112 | |
| Bottom-Line Net Income | 142↑3.1% | 138↑1.7% | 136↑104.2% | 66↓40.6% | 112 | |
| EPS (Basic) | 3.03↓3.5% | 3.14↑0.3% | 3.13↑501.9% | 0.52↓61.8% | 1.36 | |
| EPS (Diluted) | 3.02↓3.5% | 3.13↑0.0% | 3.13↑513.7% | 0.51↓62.5% | 1.36 | |
| Weighted Average Shares | 47↑6.9% | 44↑1.1% | 43↓3.1% | 45↓2.1% | 46 | |
| Weighted Average Diluted Shares | 47↑6.7% | 44↑1.6% | 43↓3.1% | 45↓2.0% | 46 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.